Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Palbociclib Impurity 002 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. . Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338792. Molecular formula: C14H21BrN4. Mole weight: 325.25. Custom synthesis is available. Send your inquiries for more information. |  London |
| Palbociclib Impurity 022 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. . Group: Pharmaceutical. Alternative Names: tert-Butyl 4-(2-nitropyridin-3-yl)piperazine-1-carboxylate; 1779124-68-3; tert-Butyl4-(2-nitropyridin-3-yl)piperazine-1-carboxylate; SCHEMBL17550837; CS-0448403; EN300-7455913. CAS No. 1779124-68-3. Pack Sizes: 100 mg. Product ID: B2694-338796. Molecular formula: C14H20N4O4. Mole weight: 308.33. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 025 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. . Group: Pharmaceutical. Alternative Names: N-Formyl Palbociclib; Palbociclib Impurity F; Palbociclib N-Aldehyde; Palbociclib N-Formyl Impurity. CAS No. 2174002-16-3. Pack Sizes: 2 mg. Product ID: B2694-338798. Molecular formula: C25H29N7O3. Mole weight: 475.54. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 026 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. . Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-037182. Molecular formula: C28H37N7O2. Mole weight: 503.64. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 027 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. . Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338802. Molecular formula: C27H35N7O2. Mole weight: 489.61. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 028 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. . Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338803. Molecular formula: C18H24N4O. Mole weight: 312.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 029 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. . Group: Pharmaceutical. Alternative Names: 1-(2-nitropyridin-3-yl)piperazine; 1566082-34-5; GS0805; EN300-2138375. CAS No. 1566082-34-5. Pack Sizes: 2 mg. Product ID: B2694-338800. Molecular formula: C9H12N4O2. Mole weight: 208.22. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 030 | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. . Group: Pharmaceutical. Alternative Names: 1-(4-nitropyridin-3-yl)piperazine; GS0814; 1211541-02-4. CAS No. 1211541-02-4. Pack Sizes: 2 mg. Product ID: B2694-338799. Molecular formula: C9H12N4O2. Mole weight: 208.22. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 10 | Palbociclib Impurity 10 is an impurity of Palbociclib, which is a selective cyclin-dependent kinases CDK4 and CDK6 inhibitor used for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: 1-Piperazinecarboxylic acid, 4,4'-[(8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidine-2,6-diyl)bis(imino-2,5-pyridinediyl)]bis-, 1,1'-bis(1,1-dimethylethyl) ester; 1,1'-Bis(1,1-dimethylethyl) 4,4'-[(8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidine-2,6-diyl)bis(imino-2,5-pyridinediyl)]bis[1-piperazinecarboxylate]; Bis(2-methyl-2-propanyl) 4,4'-[(8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-2,6-diyl)bis(imino-2,5-pyridinediyl)]di(1-piperazinecarboxylate). CAS No. 2206135-30-8. Pack Sizes: 2 mg. Product ID: B2694-338793. Molecular formula: C41H55N11O5. Mole weight: 781.94. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 2 | Palbociclib Impurity 2 is an impurity of Palbociclib, which is a selective cyclin-dependent kinases CDK4 and CDK6 inhibitor used for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: Desoxo-palbociclib; Pyrido[2,3-d]pyrimidin-7(8H)-one, 8-cyclopentyl-6-ethenyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-; 8-Cyclopentyl-6-ethenyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one; Palbociclib Impurity D. CAS No. 2204863-06-7. Pack Sizes: 5 mg. Product ID: B2694-338794. Molecular formula: C24H29N7O. Mole weight: 431.53. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity 4 | An impurity of Palbociclib which is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor to treat ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: Pyrido[2,?3-d]?pyrimidin-7(8H)?-one, 8-cyclopentyl-6-(1-hydroxyethyl)?-5-methyl-2-[[5-(1-piperazinyl)?-2-pyridinyl]?amino]?-. CAS No. 1376615-91-6. Pack Sizes: 10 mg. Product ID: B2694-478516. Molecular formula: C24H31N7O2. Mole weight: 449.56. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Impurity F | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. . Group: Pharmaceutical. CAS No. 1023594-49-1. Pack Sizes: 100 mg. Product ID: B2694-338797. Molecular formula: C14H22N4O2. Mole weight: 278.35. Custom synthesis is available. Send your inquiries for more information. | London |
| 1,4-Bis(4-nitrophenyl)piperazine | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: 1,4-Bis(4-nitrophenyl)piperazine; 16264-05-4; Piperazine, 1,4-bis(4-nitrophenyl)-EINECS 240-371-8UNII-P6TE7B2EYY. CAS No. 16264-05-4. Pack Sizes: 100 mg. Product ID: B1476-166965. Molecular formula: C16H16N4O4. Mole weight: 328.328. Custom synthesis is available. Send your inquiries for more information. | London |
| 5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: 5-Bromo-4-chloro-N-cyclopentylpyrimidin-2-amine; 1823404-28-9; CS-0011349; D87404; 5-?Bromo-?4-?chloro-?N-?cyclopentylpyrimidin?-?2-?amine. CAS No. 1823404-28-9. Pack Sizes: 100 mg. Product ID: B1476-284923. Molecular formula: C9H11BrClN3. Mole weight: 276.56. Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Bromo-8-cyclopentyl-2-[[5-(4-Boc-1-piperazinyl)-2-pyridyl]amino]-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: 4-[6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxo-2-pyrido[2,3-d]pyrimidinyl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester; tert-butyl 4-[6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylate. CAS No. 571188-82-4. Pack Sizes: 100 mg. Product ID: B1476-282703. Molecular formula: C27H34BrN7O3. Mole weight: 584.51. Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl-6-Bromo Palbociclib | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: 6-Bromo-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one; Pyrido-[2,3-d]-pyrimidin-7-one 41. CAS No. 851067-56-6. Pack Sizes: 100 mg. Product ID: B1476-283285. Molecular formula: C22H26BrN7O. Mole weight: 484.402. Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl-6-Bromo Palbociclib Hydrochloride | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: 6-bromo-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride. CAS No. 850918-83-1. Pack Sizes: 100 mg. Product ID: B1476-284929. Molecular formula: C22H27ClBrN7O. Mole weight: 520.86. Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl Palbociclib | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-; Pyrido-[2,3-d]-pyrimidin-7-one 38. CAS No. 571190-22-2. Pack Sizes: 100 mg. Product ID: B1476-478511. Molecular formula: C22H27N7O. Mole weight: 405.506. Custom synthesis is available. Send your inquiries for more information. | London |
| 6-Desacetyl Palbociclib Hydrochloride | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: 8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride. CAS No. 571189-66-7. Pack Sizes: 100 mg. Product ID: B1476-284928. Molecular formula: C22H28ClN7O. Mole weight: 441.96. Custom synthesis is available. Send your inquiries for more information. | London |
| Pabociclib Impurity B | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: tert-butyl 4-[6-[(6-acetyl-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylate. CAS No. 1651214-74-2. Pack Sizes: 100 mg. Product ID: B1476-478509. Molecular formula: C29H37N7O4. Mole weight: 547.66. Custom synthesis is available. Send your inquiries for more information. | London |
| Pabociclib Impurity B Hydrochloride | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate hydrochloride. CAS No. 1883672-48-7. Pack Sizes: 100 mg. Product ID: B1476-284924. Molecular formula: C29H38ClN7O4. Mole weight: 584.11. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib N-oxide Hydrochloride | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: PD-0332991 hydrochloride; 1-(6-((6-Acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine 1-oxide Hydrochloride salt. Pack Sizes: 100 mg. Product ID: B1370-451980. Molecular formula: C24H30ClN7O3. Mole weight: 499.99. Custom synthesis is available. Send your inquiries for more information. | London |
| Palbociclib Pyridine N-Oxide | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 2098673-40-4. Pack Sizes: 10 mg. Product ID: B2694-376322. Molecular formula: C24H29N7O3. Mole weight: 463.54. Custom synthesis is available. Send your inquiries for more information. | London |
| Parecoxib Impurity 24 | An impurity of Parecoxib. The prodrug Parecoxib as well as its active metabolite val have a specific affinity to the cannabinoid (CB) receptor measured in CB1-expressing HEK 293 cells and rat brain tissue. Adult male Sprague-Dawley rats were administered parecoxib (10 or 30 mg kg(-1), IP) or isotonic saline twice a day starting 24 h after middle cerebral artery occlusion (MCAO) for three consecutive days. The selective COX-2 inhibitor parecoxib was delivered 20 min before or 20 min after the incision by intraperitoneal injection. Pretreatment with parecoxib markedly attenuated the pain hypersensitivity induced by incision. Group: Pharmaceutical. Alternative Names: N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyramide; 2-methyl-N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonylpropanamide; Propanamide, 2-methyl-N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]-; SCHEMBL5069872; DTXSID50627261; AS-80624; CS-0255351; F83303; 2-Methyl-N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide; 2-Methyl-N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonyl]propanamide; 2-METHYL-N-[4-(5-METHYL-3-PHENYL-1,2-OXAZOL-4-YL)BENZENESULFONYL]PROPANAMIDE; N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyramide (Palbociclib Impurity). CAS No. 198470-82-5. Pack Sizes: 5 mg. Product ID: B2694-338807. Molecular formula: C20H20N2O4S. Mole weight: 384.45. Custom synthesis is available. Sen | London |
| Tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: 4-[6-[6-(1-butoxy-vinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidin-2-ylamino]-pyridin-3-yl]-piperazine-1-carboxylic acid tert-butyl ester. CAS No. 866084-31-3. Pack Sizes: 100 mg. Product ID: B1476-283415. Molecular formula: C33H45N7O4. Mole weight: 603.768. Custom synthesis is available. Send your inquiries for more information. | London |
| tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | An impurity of Palbociclib which is a drug for the treatment of ER-positive and HER2-negative breast cancer. . Group: Pharmaceutical. CAS No. 1941177-45-2. Pack Sizes: 2 mg. Product ID: B2694-338795. Molecular formula: C29H37N7O3. Mole weight: 531.65. Custom synthesis is available. Send your inquiries for more information. | London |
| tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. CAS No. 571189-65-6. Pack Sizes: 100 mg. Product ID: B1476-284927. Molecular formula: C27H35N7O3. Mole weight: 505.61. Custom synthesis is available. Send your inquiries for more information. | London |
| Tri-O-tolylphosphine oxide | An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer. Group: Pharmaceutical. Alternative Names: 1-bis(2-methylphenyl)phosphoryl-2-methylbenzene; Phosphine oxide, tri-o-tolyl-; Phosphine oxide, tris(2-methylphenyl)-. CAS No. 6163-63-9. Pack Sizes: 100 mg. Product ID: B1476-318503. Molecular formula: C21H21OP. Mole weight: 320.372. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
